News

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.
Tesla stock fell 3% as Baird analysts downgraded the stock to neutral from outperform. Robinhood Markets and AppLovin each fell 5% [as S&P Dow Jones Indices ...
The FTSE 100 and European stocks were lacklustre on Monday morning as US and Chinese officials meet in London in a bid to ...
Global Markets Mixed; U.S.-China Trade Talks in Focus U.S. stock futures pointed to a slightly lower open Monday after gains last week buoyed by optimism around U.S.-China trade talks, and after the U ...
WPP said Chief Executive Mark Read would step down at the end of the year, kicking off the search for a successor as the London-based advertising and marketing-services group braces for what could be ...
Stocks edged lower on Monday as officials from China and the U.S. prepared to meet in London. The world’s two largest economies are trying to broker a lasting trade truce, and the outcome will matter ...
Global shares are mixed as investors focus on the result of the ongoing trade talks between Washington and Beijing ...
A strong jobs report on Friday added more fuel to a rally that has lifted the S&P 500 to within 2.4% of its all-time high.
U.S. stock futures were little changed on Sunday, following a positive week for Wall Street and ahead of renewed trade talks ...
Questions about inflation and labor-market data could influence the central bank’s decision-making, and potentially impact ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
More specifically, the market witnessed two of the wildest moves in the benchmark S&P 500 during a one-week span. Between the ...